Linked Life Data

6801813

Source:http://linkedlifedata.com/resource/pubmed/id/6801813

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6801813rdf:typepubmed:Citationlld:pubmed
pubmed-article:6801813lifeskim:mentionsumls-concept:C1704822lld:lifeskim
pubmed-article:6801813lifeskim:mentionsumls-concept:C0042971lld:lifeskim
pubmed-article:6801813lifeskim:mentionsumls-concept:C0007004lld:lifeskim
pubmed-article:6801813lifeskim:mentionsumls-concept:C1366370lld:lifeskim
pubmed-article:6801813lifeskim:mentionsumls-concept:C2732002lld:lifeskim
pubmed-article:6801813lifeskim:mentionsumls-concept:C1548161lld:lifeskim
pubmed-article:6801813lifeskim:mentionsumls-concept:C2756228lld:lifeskim
pubmed-article:6801813pubmed:issue1-2lld:pubmed
pubmed-article:6801813pubmed:dateCreated1982-5-21lld:pubmed
pubmed-article:6801813pubmed:abstractTextHuman FVIII/vWf, purified 9 000 fold, was prepared from therapeutic concentrates by gel filtration and by immuno-affinity chromatography on insolubilized immunoglobulins isolated from a rabbit immunized with the plasma of a patient devoid of FVIII R:Ag. These preparations which contain coagulant activity and agglutinate normal washed human platelets in the presence of ristocetin are immunologically pure. The carbohydrate moiety of this highly purified FVIII/vWf was submitted to analysis by gas liquid chromatography and thin layer chromatography before and after hydrazinolysis and alkaline-borohydride treatment. The total carbohydrate content is 14.4 p. cent (w/w). Man and GalNAc residues were identified, this result indicating the coexistence of N- and O-glycosidically linked glycans (70 and 30 p. cent respectively). After hydrazinolysis it was demonstrated that the N-glycosidically linked glycans do not contain GalNAc residues. One major glycan belonging to the N-acetyllactosaminic type with a bi-antennary structure has been characterized by thin layer chromatography. The alkaline-borohydride treatment procedure reduced all the FVIII/vWf GalNAc to GalNAc-ol residues, demonstrating that they are all involved in the linkage of the O-glycans with the peptide chain and consequently they cannot be in oligosaccharidic sequences inducing A-blood group activity. Furthermore, at least 10 O-glycosidically linked glycans were identified by thin layer chromatography. Thus, the high degree of heterogeneity of the FVIII/vWf carbohydrate moiety requires further structural studies in order to precise which class of glycans is involved in the biological activity of FVIII/vWf.lld:pubmed
pubmed-article:6801813pubmed:languageenglld:pubmed
pubmed-article:6801813pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:citationSubsetIMlld:pubmed
pubmed-article:6801813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6801813pubmed:statusMEDLINElld:pubmed
pubmed-article:6801813pubmed:issn0049-3848lld:pubmed
pubmed-article:6801813pubmed:authorpubmed-author:MontreuilJJlld:pubmed
pubmed-article:6801813pubmed:authorpubmed-author:GoudemandMMlld:pubmed
pubmed-article:6801813pubmed:authorpubmed-author:MazurierCClld:pubmed
pubmed-article:6801813pubmed:authorpubmed-author:FournetBBlld:pubmed
pubmed-article:6801813pubmed:authorpubmed-author:SamorBBlld:pubmed
pubmed-article:6801813pubmed:authorpubmed-author:DebeirePPlld:pubmed
pubmed-article:6801813pubmed:issnTypePrintlld:pubmed
pubmed-article:6801813pubmed:volume25lld:pubmed
pubmed-article:6801813pubmed:ownerNLMlld:pubmed
pubmed-article:6801813pubmed:authorsCompleteYlld:pubmed
pubmed-article:6801813pubmed:pagination81-9lld:pubmed
pubmed-article:6801813pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:meshHeadingpubmed-meshheading:6801813-...lld:pubmed
pubmed-article:6801813pubmed:articleTitlePreliminary results on the carbohydrate moiety of factor VIII/von Willebrand factor (FVIII/vWf).lld:pubmed
pubmed-article:6801813pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6801813pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6801813lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6801813lld:pubmed